Overview

[18F]APN-1607 PET in Subjects With AD Compared to HC

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The overall objective of this study is to compare the overall pattern of [18F]APN-1607 uptake in subjects with MCI, subjects with AD dementia, and healthy subjects.
Phase:
Phase 3
Details
Lead Sponsor:
APRINOIA Therapeutics